La cardioneuroablación es una terapia emergente en el tratamiento del síncope neuromediado, que consiste en modular la respuesta autonómica para evitar una respuesta refleja excesiva y los síncopes de repetición. Esta técnica implica la ablación de plexos ganglionares mediante diferentes técnicas.
En este episodio, la moderadora Elisabete Alzola analiza con Óscar Alcalde, Álvaro Marco y Jordi Pérez Rodón la selección de los candidatos a esta terapia y las opciones de tratamiento y seguimiento.
.
Participantes:
Elisabete Alzola Martínez de AntoñanaCardiología. Hospital Universitario de Cruces (Bizkaia)
Óscar Alcalde RodríguezHospital Universitario de Navarra (Pamplona)
Álvaro Marco del CastilloHospital Universitario 12 de Octubre (Madrid)
Jordi Pérez RodónHospital Universitari Vall d'Hebron (Barcelona). Grupo Hospitalario Quirónsalud
- Cardioneuroablation for vasovagal syncope: A systematic review and meta-analysis. Heart Rhythm. 2022 Jun 16:S1547-5271(22)02088-4. doi: 10.1016/j.hrthm.2022.06.017. Epub ahead of print. PMID: 35716859.
- Cardioneuroablation for neurocardiogenic syncope. Heart Rhythm. 2019 Oct;16(10):1552-1553. doi: 10.1016/j.hrthm.2019.08.008. Epub 2019 Aug 9. PMID: 31404659.
- The benefit of cardioneuroablation to reduce syncope recurrence in vasovagal syncope patients: a case-control study. J Interv Card Electrophysiol. 2022 Jan;63(1):77-86. doi: 10.1007/s10840-020-00938-0. Epub 2021 Feb 1. PMID: 33527216.
- 2018 ESC Guidelines for the diagnosis and management of syncope, European Heart Journal, Volume 39, Issue 21, 01 June 2018, Pages 1883–1948, https://doi.org/10.1093/eurheartj/ehy037
- Clinical controversy: methodology and indications of cardioneuroablation for reflex syncope. Europace. 2023 May 19;25(5):euad033. doi: 10.1093/europace/euad033. PMID: 37021351; PMCID: PMC10227654.
- Durable Physiological Changes and Decreased Syncope Burden 12 Months After Unifocal Right-Sided Ablation Under Computed Tomographic Guidance in Patients With Neurally Mediated Syncope or Functional Sinus Node Dysfunction. Circ Arrhythm Electrophysiol. 2021 Jun;14(6):e009747. doi: 10.1161/CIRCEP.120.009747. Epub 2021 May 17. PMID: 33999698; PMCID: PMC8208097.
- Endocardial autonomic denervation in a patient with neurally mediated syncope and severe cardioinhibitory response. Rev Esp Cardiol (Engl Ed). 2020 Nov;73(11):959-961. English, Spanish. doi: 10.1016/j.rec.2020.04.019. Epub 2020 Jun 26. PMID: 32600993.
- Cardioneuroablation for vasovagal syncope and atrioventricular block: a step by‐step guide. J Cardiovasc Electrophysiol. 2022;33:2205‐2212. doi:10.1111/jce.15480
- Clinical controversy: methodology and indications of cardioneuroablation for reflex syncope. EP Europace, Volume 25, Issue 5, May 2023, euad033, https://doi.org/10.1093/europace/euad033
- Cardioneuroablation: A clinically useful vagal ablation. https://doi.org/10.1016/j.repc.2023.01.016
- Management strategies for vasovagal syncope. Pacing Clin Electrophysiol. 2021;44:2100–2108. https://doi.org/10.1111/pace.14402
- Benefit of Pacemaker Therapy in Patients With Presumed Neurally Mediated Syncope and Documented Asystole Is Greater When Tilt Test Is Negative. Arrhythm Electrophysiol is available at http://circep.ahajournals.org. DOI: 10.1161/CIRCEP.113.001103
- ‘‘Cardioneuroablation’’ e new treatment for neurocardiogenic syncope, functional AV block and sinus dysfunction using catheter RF-ablation. EP Europace, Volume 7, Issue 1, 2005, Pages 1–13, https://doi.org/10.1016/j.eupc.2004.10.003
- Endocardial Autonomic Denervation of the Left Atrium to Treat Vasovagal Syncope: An Early Experience in Humans. Circ Arrhythm Electrophysiol. 2012;5:279-286. DOI: 10.1161/CIRCEP.111.966465
- Neurocardiogenic syncope: Pacemaker or cardioneuroablation? Heart Rhythm, Vol 17, No 5PA, May 2020. DOI: https://doi.org/10.1016/j.hrthm.2020.02.026
- Simplified Cardioneuroablation in the Treatment of Reflex Syncope, Functional AV Block, and Sinus Node Dysfunction. Pacing Clin Electrophysiol. 2016 Jan;39(1):42-53. doi: 10.1111/pace.12756. Epub 2015 Oct 26
